Purpose: The pharmacology, pharmacokinetics, clinical efficacy, and safety of rasagiline are reviewed. Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and ...

Coadministration of rasagiline and ciprofloxacin (a CYP1A2 inhibitor) increases the AUC of rasagiline by 83%. [47] Thus, potent CYP1A2 inhibitors (e.g., ci-metidine, ciprofloxacin, fluvoxamine ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...